NASDAQ:SILO

Silo Pharma Q3 2026 Earnings Results & Report

Silo Pharma logo
$1.67 +0.10 (+6.29%)
As of 10:55 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Silo Pharma beat analyst earnings expectations in its Q3 2026 results, released November 13, 2026. The company reported EPS of -$0.21 versus the -$4.80 consensus estimate.

Earnings Announcement Details

Quarter
Q3 2026
Time
After Market Closes

Silo Pharma EPS Results

Actual EPS
-$0.21
Consensus EPS
-$4.80
Beat/Miss
Beat by +$4.59
One Year Ago EPS
N/A

Silo Pharma Revenue Results

Actual Revenue
N/A
Expected Revenue
$18 thousand
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Silo Pharma's next earnings date is estimated for Wednesday, December 2, 2026, based on past reporting schedules.

Conference Call Resources

Silo Pharma Q3 2026 Earnings FAQ

Silo Pharma (NASDAQ:SILO) reported earnings of -$0.21 per share for Q3 2026, beating the consensus estimate of -$4.80. The report was announced on Friday, November 13, 2026.

Silo Pharma's next earnings date is estimated for Wednesday, December 2, 2026. MarketBeat tracks confirmed and estimated earnings dates for Silo Pharma on the company's earnings history page.

Silo Pharma Earnings Headlines

Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
See More Silo Pharma Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Silo Pharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Silo Pharma and other key companies, straight to your email.

About Silo Pharma

Silo Pharma (NASDAQ:SILO) is a development-stage biopharmaceutical company focused on treatments for central nervous system disorders and pain conditions. Its research programs include potential therapies for post-traumatic stress disorder, Alzheimer’s disease and chronic pain.

The company works on drug candidates and delivery approaches involving compounds such as ketamine, including formulations intended to support targeted or sustained treatment. Silo’s programs remain in development, and the company does not have a marketed product.

View Silo Pharma Profile